financetom
Business
financetom
/
Business
/
TJX Boosts Q1 Sales With More Shoppers, Says Tariffs Won't Hurt 2026 Outlook
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
TJX Boosts Q1 Sales With More Shoppers, Says Tariffs Won't Hurt 2026 Outlook
May 26, 2025 11:36 AM

TJX Companies Inc ( TJX ) shares are trading lower premarket on Wednesday after the first-quarter FY26 earnings result.

Sales rose 5% year-over-year (Y/Y) to $13.1 billion, beating the analyst consensus estimate of $13.0 billion.

Overall comp store sales increased 3% (Y/Y), at the high end of the company's plan, and were driven by an increase in customer transactions.

Also Read: TJX Companies ( TJX ) Q1 Preview: Report Could Reflect Durable Earnings Growth

Gross profit margin was 29.5%, a 0.5 percentage point decrease versus the prior year, due to negative mark-to-market adjustments on inventory hedges.

Ernie Herrman, president and CEO said, ”All divisions, both in the U.S. and internationally, drove increases in comp sales and customer transactions, which underscores the strength of our value proposition.”

Adjusted EPS of 92 cents beat the consensus estimate of 90 cents.

The company held $4.3 billion in cash and equivalents as of May 3 and generated $394 billion of operating cash flow in the quarter.

As of May 3, total inventories stood at $7.1 billion, compared to $6.2 billion last year.

During the first quarter, the company returned a total of $1.0 billion to shareholders, including the repurchase of shares worth $613 million.

The company continues to expect share repurchases of approximately $2.0 billion to $2.5 billion in fiscal 2026.

Outlook: TJX reaffirmed guidance for FY26 comparable sales growth of 2% – 3% and EPS of $4.34-$4.43 against a $4.49 estimate.

The company sees second quarter comparable sales growth of 2% – 3% and EPS of $0.97-$1.00 with an estimate of $1.03.

TJX’s second-quarter and FY26 guidance assumes current U.S. import tariffs from China and other nations, as of Wednesday, will persist.

Furthermore, for the full-year FY26, the company expects to fully offset the significant and ongoing tariff-related financial pressures.

Investors can gain exposure to the stock via VanEck Retail ETF ( RTH ) and iShares U.S. Consumer Focused ETF .

Price Action: TJX shares are down 1.88% at $132.39 premarket at the last check on Wednesday.

Read Next

US Stocks Likely To Open Lower, Expert Says ‘Tariffs Remain A Headwind,’ But ‘Tax Cut’ And ‘Easing Of Tensions’ In Middle East ‘Could Propel Equities Closer To All-Time Highs’

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Terns Pharmaceuticals Prices $150.2 Million Public Offering
Terns Pharmaceuticals Prices $150.2 Million Public Offering
Sep 11, 2024
03:56 AM EDT, 09/11/2024 (MT Newswires) -- Terns Pharmaceuticals ( TERN ) said Tuesday it has priced a public offering of about 11.9 million common shares at $10.50 per share and pre-funded warrants to purchase 2.4 million common shares at $10.4999 per pre-funded warrant. Gross proceeds from the offering, expected to close Thursday, are estimated to be about $150.2 million,...
MOVES-Goldman Sachs appoints three co-heads of Asia M&A to bolster regional presence
MOVES-Goldman Sachs appoints three co-heads of Asia M&A to bolster regional presence
Sep 11, 2024
HONG KONG, Sept 11 (Reuters) - Goldman Sachs ( GS ) has appointed Raghav Maliah, Yoshihiko Yano and Ed Wittig as co-heads of mergers and acquisitions in Asia Pacific to expand and deepen deals coverage in the region, according to an internal memo on Tuesday seen by Reuters. Wittig is joining the bank's Asia team later this year from New...
UniCredit buys 9% stake in Germany's Commerzbank, sparking takeover talk
UniCredit buys 9% stake in Germany's Commerzbank, sparking takeover talk
Sep 11, 2024
FRANKFURT/MILAN (Reuters) -Italy's UniCredit said on Wednesday it had acquired a 9% stake in Commerzbank and will seek approval to potentially buy more, in a move that raised the prospect of CEO Andrea Orcel preparing to take over the German lender. UniCredit paid 700 million euros ($773.2 million) for almost half of the stake by bidding for shares offered by...
Regeneron, Sanofi's Dupixent Drug Meets Main Goal in 2 Late-Stage Trials
Regeneron, Sanofi's Dupixent Drug Meets Main Goal in 2 Late-Stage Trials
Sep 11, 2024
04:08 AM EDT, 09/11/2024 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) and Sanofi ( SNY ) said Wednesday that a confirmatory phase 3 study of Dupixent met primary and key secondary goals in treating patients with uncontrolled, biologic-naive chronic spontaneous urticaria receiving background therapy with antihistamines. The study showed that Dupixent added to standard-of-care reduced itch severity from baseline...
Copyright 2023-2026 - www.financetom.com All Rights Reserved